Bio-Rad Laboratories (BIO) Total Debt Growth (3y) (2012 - 2026)
Bio-Rad Laboratories (BIO) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -13.48% |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | 10.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.20% |
| Mar 31, 2026 | 0.14% |
| Dec 31, 2025 | 0.13% |
| Sep 30, 2025 | 0.17% |
| Jun 30, 2025 | 44.79% |
| Mar 31, 2025 | 44.76% |
| Dec 31, 2024 | 377.99% |
| Sep 30, 2024 | 360.04% |
| Jun 30, 2024 | 357.47% |
| Mar 31, 2024 | 356.20% |
| Dec 31, 2023 | 340.28% |
| Sep 30, 2023 | 39.80% |
| Jun 30, 2023 | 39.81% |
| Mar 31, 2023 | 39.82% |
| Dec 31, 2022 | 39.67% |
| Sep 30, 2022 | 39.67% |
| Jun 30, 2022 | -3.40% |
| Mar 31, 2022 | -3.39% |
| Dec 31, 2021 | -70.74% |
| Sep 30, 2021 | -69.63% |